EXPERIENCES

COVID-19 Experience

NO. YEAR PHASE STUDY TYPE INDICATION
1 2023 IIT Local COVID-19 치료제
2 2023 III Local COVID-19 치료제
3 2023 I Local COVID-19 Vaccine
4 2022 Medical Device Local COVID-19 진단키트
5 2022 PMS Local COVID-19 Vaccine
6 2022 III Global COVID-19 치료제
7 2022 Pilot study Local COVID-19 치료제
8 2022 I/IIa Local COVID-19 Vaccine
9 2022 III Local COVID-19 치료제
10 2022 III Global COVID-19 치료제
11 2021 III Local COVID-19 치료제
12 2021 Consulting Local COVID-19 치료제
13 2021 II Local COVID-19 치료제
14 2021 Consulting Local COVID-19 치료제
15 2021 II Local COVID-19 치료제
16 2021 II/III Local COVID-19 치료제
17 2021 III Global COVID-19 Vaccine
18 2021 Consulting Global COVID-19 Vaccine
19 2021 I/IIa Local COVID-19 Vaccine
20 2021 II/III Global COVID-19 치료제
21 2021 II Local COVID-19 치료제
22 2021 I/II Local COVID-19 치료제
23 2021 II Local COVID-19 치료제
24 2021 III Local COVID-19 치료제
25 2021 I/IIa Local COVID-19 Vaccine
26 2021 II Local COVID-19 치료제
27 2020 I/II Local COVID-19 Vaccine
28 2020 I Local COVID-19 치료제
29 2020 III Global COVID-19 Vaccine
30 2020 II Local COVID-19 치료제
31 2020 II Global COVID-19 치료제
32 2020 II Local COVID-19 치료제
33 2020 II Local COVID-19 치료제
34 2020 II Local COVID-19 치료제
35 2020 I/IIa Local COVID-19 Vaccine
36 2020 I/IIa Local COVID-19 Vaccine
37 2020 Medical Device Local COVID-19 진단키트
38 2020 I/IIa Local COVID-19 치료제
[As of 2023.12.31]
02_04_kr 치료제 백신 진단키트 2520 15 10 5 0

* LSK Global PS 는 COVID-19 극복을 위해 치료제 개발 25건(Global 4, Local 21), 백신 개발 11건(Global 3, Local 8)과 진단키트 개발 2건의 임상시험을 수행하였습니다. (2023년 12월 31일 기준)